New software to deliver faster and more-accurate diagnoses of genetic epilepsy is the ambition of a partnership between Congenica and FutureNeuro, the research center for chronic and rare neurological diseases at Science Foundation Ireland.
Read More
Rapid whole-genome sequencing is making a difference for acutely ill newborns.
Read More
With its acquisition of Maine Biotechnology Services, BBI Solutions has added more than 80 new antibodies to its growing product portfolio, as well as custom antibody development services.
Read More
Siemens Healthineers has received FDA premarket notification clearance for its blood urea nitrogen and total carbon dioxide point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.
Read More
As part of its breakthrough devices program, FDA reviewed and authorized for marketing the Banyan Brain Trauma Indicator from Banyan Biomarkers in less than 6 months.
Read More